Although bone mesenchymal stem cell (BMSC) transplantation has been applied to the treatment of spinal cord injury (SCI), the effect is unsatisfactory due to the specific microenvironment (inflammation and oxidative stress) in the SCI area, which leads to the low survival rate of transplanted cells. Thus, additional strategies are required to improve the efficacy of transplanted cells in the treatment of SCI. Hydrogen possesses antioxidant and anti-inflammatory properties. However, whether hydrogen can enhance the effect of BMSC transplantation in the treatment of SCI has not yet been reported. This study was aimed at investigating whether hydrogen promotes the therapeutic effect of BMSC transplantation in the treatment of SCI in rats. In vitro, BMSCs were cultured in a normal medium and a hydrogen-rich medium to study the effect of hydrogen on the proliferation and migration of BMSCs. BMSCs were treated with a serum-deprived medium (SDM), and the effects of hydrogen on the apoptosis of BMSCs were studied. In vivo, BMSCs were injected into the rat model of SCI. Hydrogen-rich saline (5 ml/kg) and saline (5 ml/kg) were given once a day via intraperitoneal injection. Neurological function was evaluated using the Basso, Beattie, and Bresnahan (BBB) and CatWalk gait analyses. Histopathological analysis, oxidative stress, inflammatory factors (TNF-α, IL-1β, and IL-6), and transplanted cell viability were detected at 3 and 28 days after SCI. Hydrogen can significantly enhance BMSC proliferation and migration and tolerance to SDM. Hydrogen and BMSC codelivery can significantly enhance neurological function recovery by improving the transplant cell survival rate and migration. Hydrogen can enhance the migration and proliferation capacity of BMSCs to repair SCI by reducing the inflammatory response and oxidative stress in the injured area. Hydrogen and BMSC codelivery is an effective method to improve BMSC transplantation in the treatment of SCI.

椎间盘退行性变（IDD）是脊柱外科常见病和多发病,会引起一系列临床症状,是下腰痛及颈肩痛的主要原因,严重影响患者生活质量。IDD是一个多因素过程,包括基因因素、代谢和生物力学损伤等。发生退行性变的椎间盘会通过应力失衡、血供障碍、免疫反应、炎性因子介导等相关因素进一步导致相应症状及疾病的发生,而这些过程都

目的:研究低氧预处理骨髓间充质干细胞(bone mesenchymal stem cells,BMSCs)移植对大鼠急性脊髓损伤(spinal cordinjury,SCI)治疗效果的影响并探讨其可能的机制.方法:转绿色荧光蛋白(green fluorescent protein,GFP)基因的SD大鼠10只,体重55.6±4.2(50～60)g,通过改良全骨髓贴壁法从大鼠骨髓中分离培养大鼠BMSCs并进行并进行细胞纯度和分化能力鉴定.应用0、10、50、100、200和300μM的二氯化钴(CoCl2)低氧预处理BMSCs后,通过CCK-8法检测低氧对细胞增殖的影响,细胞血清剥夺培养0、6、12和24h后,流式细胞法检测血清剥夺对细胞凋亡的影响,Transwell法检测低氧对BM-MSCs培养6、12、24h后细胞迁移的影响,流式细胞法检测低氧对细胞凋亡的影响,PCR法检测相关分子通路,找出合适的低氧处理条件.体内实验,使用Allen法垂直打击建立SCI模型,实验分为A组(假手术组)、B组(对照组)、C组(BMSCs组)和D组(H-BMSCs组)(n=20).A组的大鼠进行外科手术,但不锤击脊髓,B、C和D组均进行锤击脊髓行SCI造模和蛛网膜下腔注射注射生理盐水和低氧预处理前后的BMSCs.通过术前,术后1、3、7、10、14、21、28天BBB评分研究大鼠的神经功能恢复,术后72h免疫荧光染色法确定移植细胞的存活情况和小胶质细胞激活情况,术后72h和28dHE染色评估脊髓组织病理损伤情况.结果:CCK-8结果表明CoCl2浓度越高对BMSCs增值能力抑制越大,100μM CoCl2培养24h可以明显降低BMSCs增殖(P＜0.05),提高BMSCs的凋亡(P＜0.05),但能够显著增强预处理后BMSCs 6和12h后的细胞迁移的数量(P＜0.05),显著降低细胞血清剥夺培养24h后细胞凋亡率(P＜0.05).动物实验,与B组相比,C组的治疗可显著提高14d、21d和28d的BBB评分(P＜0.05).D组的BBB评分在21d和28d时明显高于C组(P＜0.05).HE染色结果显示,BMSC移植可以显著减少脊髓损伤部位细胞死亡,出血和炎性细胞浸润,而与C组相比,D组中的脊髓病理学损伤更轻微.细胞移植72h后,在C组和D组中均可见绿色荧光细胞,且绿色荧光的细胞数量D组(254.0±35.5)中明显高于C组(143.2±22.3,P＜0.05).SCI 72h后Iba-1免疫荧光染色显示,与B组(759.0±114.3)相比,BMSC (544.8±37.1)和D组(422.4±56.0)小胶质细胞数明显减少(P＜0.05),且D组抑制小胶质细胞激活的能力更强(P＜0.05).结论:低氧预处理BMSCs通过提高移植细胞的存活率,增强抑制小胶质细胞的激活能力,提高了SCI后大鼠神经功能的恢复,机制为低氧预处理能够增强细胞的抗损伤和迁移能力,是一种提高BMSCs移植治疗SCI疗效的有效手段.

Background: Osteosarcoma, which originates in the mesenchymal tissue, is the prevalent primary solid malignancy of the bone. It is of great importance to explore the mechanisms of metastasis and recurrence, which are two primary reasons accounting for the high death rate in osteosarcoma. Data and methods: Three miRNA expression profiles related to osteosarcoma were downloaded from GEO DataSets. Differentially expressed miRNAs (DEmiRs) were screened using MetaDE. ES of the MetaDE package. A support vector machine (SVM) classifier was constructed using optimal miRNAs, and its prediction efficiency for recurrence was detected in independent datasets. Finally, a co-expression network was constructed based on the DEmiRs and their target genes. Results: In total, 78 significantly DEmiRs were screened. The SVM classifier constructed by 15 miRNAs could accurately classify 58 samples in 65 samples (89.2%) in the GSE39040 database, which was validated in another two databases, GSE39052 (84.62%, 22/26) and GSE79181 (91.3%, 21/23). Cox regression showed that four miRNAs, including hsa-miR-10b, hsa-miR-1227, hsa-miR-146b-3p, and hsa-miR-873, significantly correlated with tumor recurrence time. There were 137, 147, 145, and 77 target genes of the above four miRNAs, respectively, which were assigned to 17 gene ontology functionally annotated terms and 14 Kyoto Encyclopedia of Genes and Genomes pathways. Among them, the "Osteoclast differentiation" pathway contained a total of seven target genes and was analyzed further. Conclusion: The 15-miRNAs-based SVM classifier provides a potential useful tool to predict the recurrence of osteosarcoma. Our results suggest the possible mechanisms of osteosarcoma metastasis and recurrence and provide fresh DEmiRs as potential biomarkers or therapeutic targets for osteosarcoma.